Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 ...

Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Pharmacy benefit leaders at ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

New Delhi: Danish pharmaceutical firm Novo Nordisk on Tuesday launched in India its anti-obesity drug Wegovy, indicated for both long-term chronic weight management and reduction in risk of major ...

Hyderabad: Health care experts have cautioned people on relying on medications for overcoming the problem of obesity, stating ...

As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...